针对神经母细胞瘤中的长非编码RNA:进展和前景
Ali Ataei1, Mahsa Tahsili2, Golsa Hayadokht3
1School of Medicine, Bam University of Medical Sciences, Bam, Iran.
Chemical biology & drug design
|June 9, 2023
概括
长非编码RNAs (lncRNAs) 正在成为神经母细胞瘤 (NB) 发展的关键参与者. 了解ncRNA的作用为诊断和治疗高风险神经母细胞瘤患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 神经母细胞瘤 (NB) 是一种普遍存在的儿童癌症,高风险患者的存活率较低.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发展中的作用.
- 在NB病变发生过程中对lncRNA的研究是一个近期但快速发展的领域.
研究的目的:
- 审查目前对神经母细胞瘤中lncRNA参与的理解.
- 讨论 lncRNAs 在 NB 发育中的病理作用.
- 探索lncRNAs作为NB预后和治疗的生物标志物的潜力.
主要方法:
- 对调查神经母细胞瘤中 lncRNAs 的研究进行文献综述.
- 对NB中失调的lncRNAs的功能和病理影响的分析.
- 对NB的基于lncRNA的生物标志物的现有证据的综合.
主要成果:
- lncRNAs与神经母细胞瘤的发病有关.
- 特定的lncRNAs表现出与NB发展相关的失调.
- 几种lncRNA显示出作为诊断或预后生物标志物的潜力.
结论:
- lncRNAs代表了理解和潜在治疗神经母细胞瘤的一个有希望的领域.
- 对lncRNA功能的进一步研究对于临床应用至关重要.
- lncRNAs可能为神经母细胞瘤提供新的治疗点和生物标志物.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K